Inhibition of tumourigenicity of small cell lung cancer cells by suppressing Id3 expression

International Journal of Oncology

Volumn 37, Issue 3, 2010, Pages 595-603

  Kamalian, Laleh ^a   Forootan, Shiva S ^a   Bao, Zheng Z ^a   Zhang, Yu ^a   Gosney, John R ^a   Foster, Christopher S ^a   Ke, Youqiang ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Id3 expression; Small cell lung cancer

Indexed keywords

CAMPTOTHECIN; CYTOTOXIN; INHIBITOR OF DIFFERENTIATION 3; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; INOCULATION; LUNG SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; BASE SEQUENCE; CAMPTOTHECIN; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; LUNG NEOPLASMS; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA; TRANSFECTION;

EID: 77956496015     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000708     Document Type: Article

References (38)

1. Kamalian L, Gosney JR, Forootan SS, et al: Increased expression of Id family proteins in small cell lung cancer and its prognostic significance. Clin Cancer Res 14: 2318-2325, 2008. (Pubitemid 351551063)
2. Perk J, Iavarone A and Benezra R: Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer 5: 603-614, 2005.
3. Forrest S and McNamara C: Id family of transcription factors and vascular lesion formation. Arterioscler Thromb Vasc Biol 24: 2014-2020, 2004.
4. Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H: The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59, 1990. (Pubitemid 120034878)
5. Moldes M, Boizard M, Liepvre XL, Feve B, Dugail I and Pairault J: Functional antagonism between inhibitor of DNA binding (Id) and adipocyte determination and differentiation factor 1/sterol regulatory element-binding protein-1c (ADD1/SREBP-1c) trans-factors for the regulation of fatty acid synthase promoter in adipocytes. Biochem J 344 : 873-880, 1999.
6. Pagliuca A, Gallo P, De Luca P and Lania L: Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth. Cancer Res 60: 1376-1382, 2000.
7. Guo K, Wang J, Andres V, Smith RC and Walsh K: MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 15: 3823-3829, 1995.
8. French BA, Chow KL, Olson EN and Schwartz RJ: Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter. Mol Cell Biol 11: 2439-2450, 1991.
9. Yates PR, Atherton GT, Deed RW, Norton JD and Sharrocks AD: Id helix-loop-helix proteins inhibit nucleoprotein complex formation by the TCF ETS-domain transcription factors. EMBO J 18: 968-976, 1999.
10. Roberts EC, Deed RW, Inoue T, Norton JD and Sharrocks AD: Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. Mol Cell Biol 21: 524-533, 2001. (Pubitemid 32037372)
11. Lasorella A, Iavarone A and Israel MA: Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol 16: 2570-2578, 1996.
12. Iavarone A, Garg P, Lasorella A, Hsu J and Israel MA: The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev 8: 1270-1284, 1994. (Pubitemid 24985787)
13. Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999.
14. Chassot AA, Turchi L, Virolle T, et al: Id3 is a novel regulator of p27(kip1) mRNA in early G1 phase and is required for cell-cycle progression. Oncogene 26: 5772-5783, 2007.
15. Swarbrick A, Akerfeldt MC, Lee CS, et al: Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24: 381-389, 2005.
16. Light W, Vernon AE, Lasorella A, Iavarone A and La Bonne C: Xenopus Id3 is required downstream of Myc for the formation of multipotent neural crest progenitor cells. Development 132: 1831-1841, 2005.
17. Forootan SS, Wong YC, Dodson A, et al: Increased Id-1 expression is significantly associated with poor survival of patients with prostate cancer. Hum Pathol 38: 1321-1329, 2007. (Pubitemid 47247487)
18. Wilson JW, Deed RW, Inoue T, et al: Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 61: 8803-8810, 2001.
19. Damdinsuren B, Nagano H, Kondo M, et al: Expression of Id proteins in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Int J Oncol 26: 319-327, 2005.
20. Lin CQ, Singh J, Murata K, et al: A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60: 1332-1340, 2000.
21. Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B and Birner P: Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res 61: 5703-5706, 2001.
22. Maruyama H, Kleeff J, Wildi S, et al: Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 155: 815-822, 1999.
23. Schindl M, Schoppmann SF, Strobel T, et al: Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res 9: 779-785, 2003.
24. Kebebew E, Treseler PA, Duh QY and Clark OH: The helix-loop-helix protein, Id-1, is overexpressed and regulates growth in papillary thyroid cancer. Surgery 134: 235-241, 2003. (Pubitemid 37070344)
25. Langlands K, Down GA and Kealey T: Id proteins are dynamically expressed in normal epidermis and dysregulated in squamous cell carcinoma. Cancer Res 60: 5929-5933, 2000.
26. Ishiguro A, Spirin K, Shiohara M, et al: Expression of Id2 and Id3 mRNA in human lymphocytes. Leuk Res 19: 989-996, 1995.
27. Higashikawa K, Yoneda S, Tobiume K, et al: DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma. Int J Cancer 124: 2837-2844, 2009.
28. Shuno Y, Tsuno NH, Okaji Y, et al: Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer. J Surg Res 161: 76-82, 2010.
29. Adamson J, Morgan EA, Beesley C, et al: High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 22: 2739-2749, 2003.
30. Freedman VH and Shin SI: Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355-359, 1974.
31. Zwiebel JA, Davis MR, Kohn E, Salomon DS and Kidwell WR: Anchorage-independent growth-conferring factor production by rat mammary tumor cells. Cancer Res 42: 5117-5125, 1982. (Pubitemid 13223155)
32. Rygaard K and Spang-Thomsen M: Quantitation and gompertzian analysis of tumor growth. Breast Cancer Res Treat 46: 303-312, 1997.
33. Olsen MW, Ley CD, Junker N, Hansen AJ, Lund EL and Kristjansen PE: Angiopoietin-4 inhibits angiogenesis and reduces interstitial fluid pressure. Neoplasia 8: 364-372, 2006.
34. Rosti G, Carminati O, Monti M, Tamberi S and Marangolo M: Chemotherapy advances in small cell lung cancer. Ann Oncol 17 (Suppl. 5): 99-102, 2006.
35. Lyden D, Young AZ, Zagzag D, et al: Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670-677, 1999. (Pubitemid 129515750)
36. Kee Y and Bronner-Fraser M: To proliferate or to die: role of Id3 in cell cycle progression and survival of neural crest progenitors. Genes Dev 19: 744-755, 2005.
37. Ruzinova MB and Benezra R: Id proteins in development, cell cycle and cancer. Trends Cell Biol 13: 410-418, 2003. (Pubitemid 36897645)
38. Asirvatham AJ, Carey JP and Chaudhary J: ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate 67: 1411-1420, 2007.